- Home
- BKSY vs IMMP Comparison
BKSY vs IMMP Comparison
Compare BKSY & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKSY
- IMMP
- Stock Information
- Founded
- BKSY 2013
- IMMP 1987
- Country
- BKSY United States
- IMMP Australia
- Employees
- BKSY N/A
- IMMP N/A
- Industry
- BKSY Radio And Television Broadcasting And Communications Equipment
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- BKSY Technology
- IMMP Health Care
- Exchange
- BKSY Nasdaq
- IMMP Nasdaq
- Market Cap
- BKSY 157.7M
- IMMP 211.1M
- IPO Year
- BKSY N/A
- IMMP N/A
- Fundamental
- Price
- BKSY $11.46
- IMMP $1.86
- Analyst Decision
- BKSY Strong Buy
- IMMP Buy
- Analyst Count
- BKSY 6
- IMMP 2
- Target Price
- BKSY $20.17
- IMMP $8.50
- AVG Volume (30 Days)
- BKSY 673.8K
- IMMP 648.0K
- Earning Date
- BKSY 05-08-2025
- IMMP 05-16-2025
- Dividend Yield
- BKSY N/A
- IMMP N/A
- EPS Growth
- BKSY N/A
- IMMP N/A
- EPS
- BKSY N/A
- IMMP N/A
- Revenue
- BKSY $107,401,000.00
- IMMP $3,019,249.00
- Revenue This Year
- BKSY $32.27
- IMMP $11.25
- Revenue Next Year
- BKSY $26.94
- IMMP $10.22
- P/E Ratio
- BKSY N/A
- IMMP N/A
- Revenue Growth
- BKSY 7.05
- IMMP 24.11
- 52 Week Low
- BKSY $3.86
- IMMP $1.32
- 52 Week High
- BKSY $21.92
- IMMP $3.34
- Technical
- Relative Strength Index (RSI)
- BKSY 73.05
- IMMP 53.43
- Support Level
- BKSY $8.29
- IMMP $1.44
- Resistance Level
- BKSY $9.17
- IMMP $2.71
- Average True Range (ATR)
- BKSY 0.60
- IMMP 0.17
- MACD
- BKSY 0.39
- IMMP 0.05
- Stochastic Oscillator
- BKSY 94.72
- IMMP 29.75
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.